Cargando…

Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients

BACKGROUND: Psychological stressors may cause mental disorders such as anxiety, depression, and post-traumatic stress disorders and fibromyalgia (FM) patients could be affected by these stressors. AIM: To evaluate pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Büyükşireci, Dilek Eker, Türk, Ayla Çağlıyan, Erden, Ender, Erden, Ebru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258456/
https://www.ncbi.nlm.nih.gov/pubmed/35794340
http://dx.doi.org/10.1007/s11845-022-03081-z
_version_ 1784741558340288512
author Büyükşireci, Dilek Eker
Türk, Ayla Çağlıyan
Erden, Ender
Erden, Ebru
author_facet Büyükşireci, Dilek Eker
Türk, Ayla Çağlıyan
Erden, Ender
Erden, Ebru
author_sort Büyükşireci, Dilek Eker
collection PubMed
description BACKGROUND: Psychological stressors may cause mental disorders such as anxiety, depression, and post-traumatic stress disorders and fibromyalgia (FM) patients could be affected by these stressors. AIM: To evaluate pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in patients with FM. METHODS: According to the 2016 American College of Rheumatology (ACR) criteria, fifty-seven patients with FM alone and 77 patients with FM and recovering from COVID-19 infection were recruited to the study (group 1: patients with FM alone and group 2: patients with FM and recovering from COVID-19). Demographic and clinical characteristics were recorded. The pain level was determined by the Numerical Rating Scale (NRS), the pain regions by the Widespread Pain Index (WPI) of the 2016 ACR criteria, the severity of the symptoms by the Symptom Severity Scale (SSS) of the 2016 ACR criteria, the disease activity by the Fibromyalgia Impact Questionnaire (FIQ), the anxiety and depression levels by the Hospital Anxiety and Depression Scale (HADS), and the neuropathic pain level by Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS). RESULTS: Age, height, weight, Body Mass Index (BMI), and the duration of FM diagnosis were similar in both groups (p > 0.05). NRS, FIQ, HADS depression scale, and SSS and LANSS scores were similar between group 1 and group 2 (p > 0.05). HADS anxiety score and WPI were significantly increased in group 2 (p = 0.026 and p = 0.024 respectively). CONCLUSIONS: Anxiety and widespread pain levels were higher in patients with FM and recovering from COVID-19 infection.
format Online
Article
Text
id pubmed-9258456
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-92584562022-07-07 Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients Büyükşireci, Dilek Eker Türk, Ayla Çağlıyan Erden, Ender Erden, Ebru Ir J Med Sci Original Article BACKGROUND: Psychological stressors may cause mental disorders such as anxiety, depression, and post-traumatic stress disorders and fibromyalgia (FM) patients could be affected by these stressors. AIM: To evaluate pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in patients with FM. METHODS: According to the 2016 American College of Rheumatology (ACR) criteria, fifty-seven patients with FM alone and 77 patients with FM and recovering from COVID-19 infection were recruited to the study (group 1: patients with FM alone and group 2: patients with FM and recovering from COVID-19). Demographic and clinical characteristics were recorded. The pain level was determined by the Numerical Rating Scale (NRS), the pain regions by the Widespread Pain Index (WPI) of the 2016 ACR criteria, the severity of the symptoms by the Symptom Severity Scale (SSS) of the 2016 ACR criteria, the disease activity by the Fibromyalgia Impact Questionnaire (FIQ), the anxiety and depression levels by the Hospital Anxiety and Depression Scale (HADS), and the neuropathic pain level by Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS). RESULTS: Age, height, weight, Body Mass Index (BMI), and the duration of FM diagnosis were similar in both groups (p > 0.05). NRS, FIQ, HADS depression scale, and SSS and LANSS scores were similar between group 1 and group 2 (p > 0.05). HADS anxiety score and WPI were significantly increased in group 2 (p = 0.026 and p = 0.024 respectively). CONCLUSIONS: Anxiety and widespread pain levels were higher in patients with FM and recovering from COVID-19 infection. Springer International Publishing 2022-07-06 2023 /pmc/articles/PMC9258456/ /pubmed/35794340 http://dx.doi.org/10.1007/s11845-022-03081-z Text en © The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Büyükşireci, Dilek Eker
Türk, Ayla Çağlıyan
Erden, Ender
Erden, Ebru
Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients
title Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients
title_full Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients
title_fullStr Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients
title_full_unstemmed Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients
title_short Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients
title_sort evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after covid-19 infection in fibromyalgia patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258456/
https://www.ncbi.nlm.nih.gov/pubmed/35794340
http://dx.doi.org/10.1007/s11845-022-03081-z
work_keys_str_mv AT buyuksirecidilekeker evaluationofpaindiseaseactivityanxietydepressionandneuropathicpainlevelsaftercovid19infectioninfibromyalgiapatients
AT turkaylacaglıyan evaluationofpaindiseaseactivityanxietydepressionandneuropathicpainlevelsaftercovid19infectioninfibromyalgiapatients
AT erdenender evaluationofpaindiseaseactivityanxietydepressionandneuropathicpainlevelsaftercovid19infectioninfibromyalgiapatients
AT erdenebru evaluationofpaindiseaseactivityanxietydepressionandneuropathicpainlevelsaftercovid19infectioninfibromyalgiapatients